| Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV (NCT00545558) | University of Cincinnati | 2006-04-01 |
| Reducing HIV Risks in African American Teens (NCT00963963) | Education Development Center, Inc. | 2006-04-01 |
| Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide (NCT00441909) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks* (NCT00511368) | Myrexis Inc. | 2006-04-01 |
| Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir (NCT00365339) | Bristol-Myers Squibb | 2006-04-01 |
| When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study) (NCT00234091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-04-01 |
| Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation (NCT00312039) | Alexion Pharmaceuticals, Inc. | 2006-03-31 |
| Impact of Peer Health Workers and Mobile Phones on HIV Care (NCT00675389) | Johns Hopkins University | 2006-03-01 |
| Computer Assisted Rx Education for HIV-Positives: CARE+ (NCT00443378) | University of Washington | 2006-03-01 |
| PTSD and Risk Behavior in HIV Positive Female Adolescents (NCT00271882) | University of North Carolina, Chapel Hill | 2006-03-01 |
| BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1. (NCT00326963) | Hoffmann-La Roche | 2006-03-01 |
| Metabolic Abnormalities - HIV Infected and Uninfected Males (NCT00260936) | University of North Carolina, Chapel Hill | 2006-03-01 |
| Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies (NCT00530972) | Hospital Carlos III, Madrid | 2006-03-01 |
| CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDS (NCT00583167) | Vanderbilt University | 2006-03-01 |
| Oral Human Papillomavirus Infection in HIV-infected Men (NCT00421486) | Deutsche Luft und Raumfahrt | 2006-03-01 |
| Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy (NCT00099632) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of Chloroquine (NCT00308620) | University of Minnesota | 2006-03-01 |
| A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China (NCT00479141) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation (NCT00130910) | University of Washington | 2006-03-01 |
| Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection (NCT00183261) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients (NCT00299897) | Samaritan Pharmaceuticals, Inc | 2006-03-01 |
| Prevalence of HIV and Other Sexually Transmitted Infections Among Female Sex Workers and Miners in Honghe Prefecture, Yunnan Province, China (NCT00278499) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-01 |
| Effects of Growth Hormone in Chronically Ill Children (NCT00286689) | University of Texas Southwestern Medical Center | 2006-02-03 |
| Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children (NCT00260078) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder (NCT00316303) | Dartmouth-Hitchcock Medical Center | 2006-02-01 |
| A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175 (NCT00096824) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2006-02-01 |
| Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients (NCT00294372) | Boehringer Ingelheim | 2006-02-01 |
| Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME) (NCT00122538) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-02-01 |
| Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r (NCT00476502) | The HIV Netherlands Australia Thailand Research Collaboration | 2006-02-01 |
| PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir (NCT00273273) | University of North Carolina, Chapel Hill | 2006-02-01 |
| Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs (NCT00257127) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients (NCT00543803) | Boehringer Ingelheim | 2006-02-01 |
| HIV Prevention With the Mentally Ill (NCT00643305) | Boston Medical Center | 2006-02-01 |
| Extending HIV Care Beyond the Rural Health Center (NCT00371540) | Indiana University | 2006-02-01 |
| A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019) (NCT00293254) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Case-Control Viramune (Nevirapine) Toxicogenomics Study (NCT00310843) | Boehringer Ingelheim | 2006-02-01 |
| Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults (NCT00270218) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy (NCT00264875) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2006-02-01 |
| A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2) (NCT00293267) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Pharmacokinetics Study on Nevirapine Resistance in Tanzania (NCT00294892) | Radboud University Medical Center | 2006-02-01 |
| Screening for Lung Cancer in the HIV Patient (NCT01748136) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-01-01 |
| Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients (NCT00287677) | Germans Trias i Pujol Hospital | 2006-01-01 |
| Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART (NCT00270205) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129) (NCT00115609) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-01-01 |
| Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults (NCT00141024) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| C2P Mobilization Intervention (Pilot) (NCT00393575) | University of North Carolina, Chapel Hill | 2006-01-01 |
| The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism (NCT00259727) | US Department of Veterans Affairs | 2006-01-01 |
| Increasing Condom Use in People at Risk for HIV Infection (NCT00080093) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-01-01 |
| Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark (NCT01061957) | Rigshospitalet, Denmark | 2006-01-01 |
| The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients (NCT00306410) | Radboud University Medical Center | 2006-01-01 |
| Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs (NCT00477308) | The HIV Netherlands Australia Thailand Research Collaboration | 2006-01-01 |
| Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV (NCT00307151) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2005-12-01 |
| A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study (NCT00192634) | Kirby Institute | 2005-12-01 |
| A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity (NCT00267527) | ConjuChem | 2005-12-01 |
| Drug Interaction Study Between Antimalarial and Anti-HIV Medications (NCT00266058) | University of California, San Francisco | 2005-12-01 |
| Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127) (NCT00122603) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-12-01 |
| A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium (NCT00309205) | International Partnership for Microbicides, Inc. | 2005-12-01 |
| Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584) (NCT00736242) | Merck Sharp & Dohme LLC | 2005-12-01 |
| Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) (NCT00687544) | Merck Sharp & Dohme LLC | 2005-12-01 |
| BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada (NCT00272779) | Bristol-Myers Squibb | 2005-11-01 |
| Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis (NCT00285441) | Hvidovre University Hospital | 2005-11-01 |
| Family-based HIV Prevention for Adolescent Girls (NCT00243126) | University of North Carolina, Chapel Hill | 2005-11-01 |
| Relationship Between HIV and Malaria in Ugandan Children (NCT00356824) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults (NCT00109746) | National Center for Complementary and Integrative Health (NCCIH) | 2005-11-01 |
| Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy (NCT00126308) | Kirby Institute | 2005-11-01 |
| Yoga for the Management of HIV-Metabolic Syndromes (NCT00627380) | Washington University School of Medicine | 2005-11-01 |
| Acupuncture/Moxibustion for Peripheral Neuropathy in HIV (NCT00317291) | National Center for Complementary and Integrative Health (NCCIH) | 2005-11-01 |
| Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) (NCT00207142) | Bristol-Myers Squibb | 2005-11-01 |
| Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center (NCT00267410) | Centers for Disease Control and Prevention | 2005-11-01 |
| Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants (NCT00130819) | Johns Hopkins University | 2005-11-01 |
| A Pilot Study of LTB4 in HIV-1 Infected Adults (NCT00251537) | LTB4 Sweden AB | 2005-11-01 |
| A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience (NCT00487188) | Hoffmann-La Roche | 2005-11-01 |
| Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults (NCT00124007) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults (NCT00099684) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 |
| A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel (NCT00304642) | International Partnership for Microbicides, Inc. | 2005-11-01 |
| Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy (NCT00147355) | Kirby Institute | 2005-11-01 |
| Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid (NCT00888446) | International AIDS Vaccine Initiative | 2005-10-01 |
| Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients (NCT00140751) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2005-10-01 |
| A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel (NCT00303576) | International Partnership for Microbicides, Inc. | 2005-10-01 |
| Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection (NCT00262106) | Endo USA Inc., a Keenova Therapeutics Company | 2005-10-01 |
| Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial (NCT00373048) | Institute of Tropical Medicine, Belgium | 2005-10-01 |
| Online HIV Prevention Vignette Evaluation (NCT00249327) | Public Health Solutions | 2005-10-01 |
| Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV (NCT00356486) | Germans Trias i Pujol Hospital | 2005-10-01 |
| Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4 (NCT00612755) | Hospital Clinico Universitario San Cecilio | 2005-10-01 |
| Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection (NCT00885664) | University of Cincinnati | 2005-10-01 |
| Reducing Ethnic Health Disparities: Motivating HIV+ Latinos to Quit Smoking (NCT00503230) | Butler Hospital | 2005-10-01 |
| Study of UC-781 Vaginal Microbicide (NCT00132444) | CONRAD | 2005-10-01 |
| Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126) (NCT00117494) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-10-01 |
| Impact of Screening Patients With HIV for Kidney Disease (NCT00392132) | University of Mississippi Medical Center | 2005-10-01 |
| Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults (NCT00255944) | University of Colorado, Denver | 2005-10-01 |
| ATV/Ritonavir Nevirapine Interaction (USPAC) (NCT00162149) | Bristol-Myers Squibb | 2005-10-01 |
| Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy (NCT00232141) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-10-01 |
| Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women (NCT00102986) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-10-01 |
| Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy (NCT00476853) | The HIV Netherlands Australia Thailand Research Collaboration | 2005-10-01 |
| A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus (NCT00361101) | Genzyme, a Sanofi Company | 2005-10-01 |
| Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma (NCT00226304) | National Institutes of Health Clinical Center (CC) | 2005-09-20 |
| Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672) (NCT00243230) | Merck Sharp & Dohme LLC | 2005-09-19 |
| Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People (NCT00110812) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs (NCT00183456) | Johns Hopkins Bloomberg School of Public Health | 2005-09-01 |
| TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada (NCT00323492) | Gilead Sciences | 2005-09-01 |